Kura Oncology, Inc. (KURA) vs Odyssey Therapeutics, Inc. (ODTX)
A side-by-side comparison of Kura Oncology, Inc. and Odyssey Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KURA
Kura Oncology, Inc.
$10.57HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
ODTX
Odyssey Therapeutics, Inc.
$18.45HealthcareDelayed quote: Oct 6, 2026, 2:18 PM EDT
Total return — KURA vs ODTX
growth of $100 · dividends reinvested · last 1yKURA +12.7% (+12.7%/yr)ODTX +26.9% (+26.9%/yr)ODTX compounded faster over this window
KURA ODTX
KURA vs ODTX: by the numbers
- •KURA is the larger company ($938M vs $886M market cap).
- •Both run net losses; KURA's is the smaller (-384.30% vs -4994.86% net margin).
Metrics side by side
Valuation
| Metric | KURA | ODTX |
|---|---|---|
| P/S ratio | 12.15 | N/A |
| P/B ratio | 19.37 | 2.10 |
Profitability
| Metric | KURA | ODTX |
|---|---|---|
| Gross margin | 94.73% | 100.00% |
| Operating margin | -449.94% | -5415.19% |
| Net margin | -384.30% | -4994.86% |
| ROE | -612.78% | N/A |
| ROIC | -67.13% | -66.23% |
Growth (annualized)
| Metric | KURA | ODTX |
|---|---|---|
| Total return CAGR (5Y) | -10.73% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.